Extension Notice for Revolving Credit Facility between Bristol-Myers Squibb Company and Citibank, N.A.

Summary

Bristol-Myers Squibb Company has formally requested an extension of the maturity date for its existing revolving credit facility, originally set to mature on September 29, 2024. The company is asking the lenders, including Citibank, N.A. as Administrative Agent, to extend the maturity date by one year to September 29, 2025. This notice serves as the official request under the terms of the original credit agreement.

EX-10.F 2 bmyex10f20210630.htm EXTENSION NOTICE FOR REVOLVING CREDIT FACILITY DATED SEPTEMBER 29, 2011 Document
EXHIBIT 10f

Citibank, N.A., as Administrative Agent
388 Greenwich Street
New York, New York 10013
Attention: Richard Rivera


June 1, 2021

Ladies and Gentlemen:

Re: Extension of Maturity Date

Reference is made to the Five Year Competitive Advance and Revolving Credit Facility Agreement, dated as of September 29, 2011 (as amended, supplemented or otherwise modified prior to the date hereof, the “Credit Agreement”) among Bristol-Myers Squibb Company, a Delaware corporation (the “Company”), the Borrowing Subsidiaries, the lenders parties thereto (the “Lenders”), certain Agents, Citibank , N.A., as an Administrative Agent, and JPMorgan Chase Bank, N.A., as an Administrative Agent. Capitalized terms used but not defined herein shall have the meaning assigned to such terms in the Credit Agreement.

Pursuant to Section 2.5 of the Credit Agreement, the Company hereby requests that the Lenders extend the Maturity Date in effect on the date hereof (i.e., September 29, 2024) such that the extended Maturity Date under the Credit Agreement will be September 29, 2025. This letter shall constitute an “Extension Letter” as referred to in Section 2.5 of the Credit Agreement.


BRISTOL-MYERS SQUIBB COMPANY
/s/ Sandra Ramos-Alves
Name: Sandra Ramos-Alves
Title: Vice President and Assistant Treasurer